Vyvgart

target reach ladder climb meet win beat competition

Biotech

J&J's phase 2 Sjögren's data support FcRn strategy

Patients who received the 15-mg/kg dose demonstrated a more than 70% improvement in the primary endpoint of a measure of organ disease severity.

James Waldron Jun 17, 2024 8:47am

long distance runners race ultramarathon marathon

Immunovant promotes next-gen FcRn drug in race to rival Vyvgart

May 30, 2024 7:02am